Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

So long, Sora — and so long, $1 billion from the Mouse House.

No Lazy Kid: 12-year-old app developer off to fast start Ethan Duggan’s app career began with an at-home fashion show. His mother had returned home after clothes shopping and wanted to model her new ...

Oracle Integration Cloud (OIC) helps connect different applications and systems, both in the cloud and on-premises, making ...